154 related articles for article (PubMed ID: 6087025)
1. Expression of normal and tumor-associated antigens in human breast carcinoma.
Sawtell NM; DiPersio L; Michael JG; Pesce AJ; Weiss MA
Lab Invest; 1984 Aug; 51(2):225-32. PubMed ID: 6087025
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment.
Greiner JW; Hand PH; Noguchi P; Fisher PB; Pestka S; Schlom J
Cancer Res; 1984 Aug; 44(8):3208-14. PubMed ID: 6744259
[TBL] [Abstract][Full Text] [Related]
3. [The expression of leukocytic and related antigens on the cells of human breast cancer cells].
Tupitsyn NN; Kadagidze ZG; Blokhina NG; Baryshnikov AIu; Ermilova VD; Artamonova EV; Moldenhauer G; Bernard A
Eksp Onkol; 1990; 12(2):54-8. PubMed ID: 1690634
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells.
Natali PG; Giacomini P; Bigotti A; Imai K; Nicotra MR; Ng AK; Ferrone S
Cancer Res; 1983 Feb; 43(2):660-8. PubMed ID: 6336658
[TBL] [Abstract][Full Text] [Related]
5. Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens.
Hand PH; Nuti M; Colcher D; Schlom J
Cancer Res; 1983 Feb; 43(2):728-35. PubMed ID: 6848188
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
[TBL] [Abstract][Full Text] [Related]
8. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
Nuti M; Castagna M; Squartini F
Appl Pathol; 1984; 2(3):117-27. PubMed ID: 6085790
[TBL] [Abstract][Full Text] [Related]
9. Frequency of association of mammary tumor glycoprotein antigen and other markers with human breast tumors.
Leung JP; Bordin GM; Nakamura RM; DeHeer DH; Edgington TS
Cancer Res; 1979 Jun; 39(6 Pt 1):2057-61. PubMed ID: 221100
[No Abstract] [Full Text] [Related]
10. Tissue distribution of an epithelial and tumor-associated antigen recognized by monoclonal antibody F36/22.
Croghan GA; Papsidero LD; Valenzuela LA; Nemoto T; Penetrante R; Chu TM
Cancer Res; 1983 Oct; 43(10):4980-8. PubMed ID: 6349797
[TBL] [Abstract][Full Text] [Related]
11. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
12. Expression of HLA-A, -B, -C, -DR, -DP, -DQ, and of HLA-D-associated invariant chain (Ii) in non-neoplastic mammary epithelium, fibroadenoma, adenoma, and carcinoma of the breast.
Möller P; Mattfeldt T; Gross C; Schlosshauer P; Koch A; Koretz K; Moldenhauer G; Kaufmann M; Otto HF
Am J Pathol; 1989 Jul; 135(1):73-83. PubMed ID: 2549795
[TBL] [Abstract][Full Text] [Related]
13. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
[TBL] [Abstract][Full Text] [Related]
14. [Estrogen receptor status in breast carcinoma. Results of comparative immunohistochemical and biochemical studies].
Köhler G; Bässler R
Dtsch Med Wochenschr; 1986 Dec; 111(51-52):1954-60. PubMed ID: 3024947
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
[TBL] [Abstract][Full Text] [Related]
16. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
17. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O
Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies.
Rasmussen BB; Pedersen BV; Thorpe SM; Hilkens J; Hilgers J; Rose C
Cancer Res; 1985 Mar; 45(3):1424-7. PubMed ID: 3971385
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
Forti E; Wolf D; Melia M
Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
[No Abstract] [Full Text] [Related]
20. Relationship of monoclonal antibody binding to estrogen and progesterone receptor content in breast cancer.
Hendler FJ; Yuan D
Cancer Res; 1985 Jan; 45(1):421-9. PubMed ID: 3965148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]